The Potential for Interventional Radiologists of Peripheral Arterial Disease

ABSTRACT

It is unfortunate that in the peripheral arena surgeons often get the first referral for patients with peripheral arterial disease. Interventionalists should present themselves as vascular specialists to the referring community. Peripheral vascular disease in the future will be primarily an interventional specialty. Endovascular interventions are safe for people with claudication and interventionalists should offer them. If interventionalists provide comprehensive care and thoughtfully enter a market with the will to compete, it is very likely that they will succeed.

PAD - minimally invasive therapy - vascular specialist - interventionalist

REFERENCES

• 1 Criado F J. Reinventing the vascular surgeon.  Endovascular Today. 2004; March;  75-77 , Abstract
• 2 Weibull H, Bergqvist D, Bergentz S E, Jonsson K, Hulthen L, Manhem P. Percutaneous transluminal renal angioplasty versus surgical reconstruction of atherosclerotic renal artery stenosis: a prospective randomized study.  J Vasc Surg. 1993;  18 841-850
• 3 Wilson S E, Wolf G L, Cross A P. Percutaneous transluminal angioplasty versus operation for peripheral arteriosclerosis. Report of a prospective randomized trial in a selected group of patients.  J Vasc Surg. 1989;  9 1-9
• 4 Wolf G L, Wilson S E, Cross A P, Deupree R H, Stason W B. Surgery or balloon angioplasty for peripheral vascular disease: a randomized clinical trial. Principal investigators and their Associates of Veterans Administration Cooperative Study Number 199.  J Vasc Interv Radiol. 1993;  4 639-648
• 5 Yadav J S, Wholey M H, Kuntz R E et al.. Protected carotid-artery stenting versus endarterectomy in high-risk patients.  N Engl J Med. 2004;  351 1493-1501
• 6 Khwaja A A, Murphy T P. Intervention for intermittent claudication improves quality of life.  Diagn Imaging (San Franc). 1999;  21 63-66
• 7 American Medical Association Council on Ethical and Judicial Affaris .Code of Medical Ethics: Current Opinions with Annotations. Chicago; American Medical Association 2002 Abstract
• 8 Aliyu Z Y, Yousif S B, Plantholt K, Salihu H, Erinle A, Plantholt S. Assessing compliance of cardiologists with the national cholesterol education program (NCEP) III guidelines in an ambulatory care setting.  Lipids Health Dis. 2004;  3 9
• 9 Alzahrani T, Marrat S, Haider A. Management of dyslipidemia in primary care.  Can J Cardiol. 2003;  19 1499-1502
• 10 Bishop P B, Wing P C. Compliance with clinical practice guidelines in family physicians managing worker's compensation board patients with acute lower back pain.  Spine J. 2003;  3 442-450
• 11 Frolkis J P, Zyzanski S J, Schwartz J M, Suhan P S. Physician noncompliance with the 1993 National Cholesterol Education Program (NCEP-ATPII) guidelines.  Circulation. 1998;  98 851-855
• 12 Siddiqui A K, Ahmed S, Delbeau H, Conner D, Mattana J. Lack of physician concordance with guidelines on the perioperative use of beta-blockers.  Arch Intern Med. 2004;  164 664-667
• 13 Sinclair S H, Delvecchio C. The internist's role in managing diabetic retinopathy: screening for early detection.  Cleve Clin J Med. 2004;  71 151-159
• 14 Toth E L, Majumdar S R, Guirguis L M, Lewanczuk R Z, Lee T K, Johnson J A. Compliance with clinical practice guidelines for type 2 diabetes in rural patients: treatment gaps and opportunities for improvement.  Pharmacotherapy. 2003;  23 659-665